The salts of a compound and the crystalline forms thereof
AssigneeHutchison Medipharma Limited
InventorsWenji LI, Ling FENG
Life of this patent
Estimating the term…
Abstract
The present invention relates to the salts of a compound and the crystalline forms thereof. More specifically, the present invention belongs to the pharmaceutical field, and provides the pharmaceutically acceptable salts of the compound 4-chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethyl piperazin-1-yl) phenyl) amino) pyrimidin-5-yl) ethyl)-5-methoxy-N-methylbenzamide and the crystalline forms thereof, the pharmaceutical compositions comprising the same as well as the methods for preparing the same and the use thereof.
Claims51
A salt of Formula A:
- wherein n is 0.5 or 1;
- and M is hydrochloric acid, tartaric acid, or p-toluenesulfonic acid.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.